Glycan-dependent signaling: O-linked N-acetylglucosamine

FASEB Journal

Volumn 15, Issue 11, 2001, Pages 1865-1876

  Hanover, John A ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

Diabetes mellitus; Hexosaminidase C; O GlcNAc; OGT

Indexed keywords

BETA N ACETYLGLUCOSAMINYLTRANSFERASE; BETA N ACETYLHEXOSAMINIDASE; GLUCOSAMINE DERIVATIVE; GLYCAN DERIVATIVE; ISOPROTEIN; N ACETYLGLUCOSAMINE; N ACETYLGLUCOSAMINYLTRANSFERASE; PHOSPHATASE; PHOSPHOTRANSFERASE; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

AMINO ACID METABOLISM; CANCER; DEGENERATIVE DISEASE; DIABETES MELLITUS; ENZYME ACTIVITY; GENE; GENE OGT; GLUCOSE METABOLISM; GLYCOSYLATION; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN MODIFICATION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; PROTEIN TARGETING; REVIEW; SIGNAL TRANSDUCTION;

ACETYLGLUCOSAMINE; ACETYLTRANSFERASES; ANIMALS; GLUCOSE; HEXOSAMINES; HUMANS; POLYSACCHARIDES; SIGNAL TRANSDUCTION;

EMBRYOPHYTA; MAMMALIA;

EID: 0034854157     PISSN: 08926638     EISSN: None     Source Type: Journal    
DOI: 10.1096/fj.01-0094rev     Document Type: Review

References (132)

1. Topography and polypeptide distribution of terminal N-acetylglucosamine residues on the surfaces of intact lymphocytes. Evidence for O-linked GlcNAc
2. Erythrocytes contain cytoplasmic glycoproteins. O-linked GlcNAc on band 4.1.
3. The subcellular distribution of terminal N-acetylglucosamine moieties. Localization of a novel protein-saccharide linkage, O-linked GlcNAc
4. O-linked N-acetylglucosamine is attached to proteins of the nuclear pore. Evidence for cytoplasmic and nucleoplasmic glycoproteins
5. Nuclear pore complex glycoproteins contain cytoplasmically disposed O-linked N-acetylglucosamine
6. Monoclonal antibodies identify a group of nuclear pore complex glycoproteins
7. A monoclonal antibody against a family of nuclear pore proteins (nucleoporins): O-linked N-acetylglucosamine is part of the immunodeterminant
8. O-glycosylation of eukaryotic transcription factors: Implications for mechanisms of transcriptional regulation
9. Glycosylation of chromosomal proteins: Localization of O-linked N-acetylglucosamine in Drosophila chromatin
10. Enzymatic addition of O-GlcNAc to nuclear and cytoplasmic proteins. Identification of a uridine diphospho-N-acetylglucosamine: Peptide beta-N-acetylglucosaminyltransferase
11. Glycosylation of nuclear pore protein p62. Reticulocyte lysate catalyzes O-linked N-acetylglucosamine addition in vitro
12. Purification and characterization of an O-GlcNAc selective N-acetyl-beta-D-glucosaminidase from rat spleen cytosol
13. Dynamic O-glycosylation of nuclear and cytosolic proteins: Cloning and characterization of a neutral, cytosolic β-N-acetylglucosaminidase from human brain
14. Functional nuclear pores reconstituted with beta galactose-modified O-linked N-acetylglucosamine glycoproteins
15. Nuclear protein import: Specificity for transport across the nuclear pore
16. Lymphocyte activation induces rapid changes in nuclear and cytoplasmic glycoproteins
17. c-Myc is glycosylated at threonine 58, a known phosphorylation site and a mutational hot spot in lymphomas
18. Glycosylation of the c-Myc transactivation domain
19. O-GlcNAc and the control of gene expression
20. Glucose regulation of transforming growth factor-alpha expression is mediated by products of the hexosamine biosynthesis pathway
21. Glycosylation of eukaryotic peptide chain initiation factor 2 (eIF-2)-associated 67-kDa polypeptide (p67) and its possible role in the inhibition of eIF-2 kinase-catalyzed phosphorylation of the eIF-2 alpha-subunit
22. Interaction of the transcription factor Sp1 with the nuclear pore protein p62 requires the C-terminal domain of p62
23. A subpopulation of estrogen receptors are modified by O-linked N-acetylglucosamine
24. Localization of O-GlcNAc modification on the serum response transcription factor
25. O glycosylation of an Sp1-derived peptide blocks known Sp1 protein interactions
26. Dynamic glycosylation of nuclear and cytosolic proteins. Cloning and characterization of a unique O-GlcNAc transferase with multiple tetratricopeptide repeats
27. O-Linked GlcNAc transferase is a conserved nucleocytoplasmic protein containing tetratricopeptide repeats
28. Regulation of a cytosolic and nuclear O-GlcNAc transferase. Role of the tetratricopeptide repeats
29. Functional expression of O-linked GlcNAc transferase. Domain structure and substrate specificity
30. The O-GlcNAc transferase gene resides on the X chromosome and is essential for embryonic stem cell viability and mouse ontogeny
31. The topological orientation of N,N′-diacetylchitobiosylpyrophosphoryldolichol in artificial and natural membranes
32. Cytologic assessment of nuclear and cytoplasmic O-linked N-acetylglucosamine distribution by using anti-streptococcal monoclonal antibodies
33. Selective detection and site-analysis of O-GlcNAc-modified glycopeptides by beta-elimination and tandem electrospray mass spectrometry
34. Specific isolation of O-linked N-acetylglucosamine glycopeptides from complex mixtures
35. An in vivo approach for the identification of acceptor sites for O-glycosyltransferases: Motifs for the addition of O-GlcNAc in Dictyostelium discoideum
36. High-sensitivity FAB-MS strategies for O-GlcNAc characterization
37. Vertebrate lens alpha-crystallins are modified by O-linked N-acetylglucosamine
38. Plant nuclear pore complex proteins are modified by novel oligosaccharides with terminal N-acetylglucosamine
39. A glycoprotein modified with terminal N-acetylglucosamine and localized at the nuclear rim shows sequence similarity, to aldose-l-epimerases
40. Gibberellin signal transduction presents ellipsis the SPY who O-GlcNAc'd me
41. NMR assignments for glycosylated and galactosylated N-acetylhexosaminitols: Oligosaccharide alditols related to O-linked glycans from the protozoan parasite Trypanosoma cruzi
42. Trypanosoma cruzi surface mucins with exposed variant epitopes
43. Structural characterization of the major glycosylphosphatidylinositol membrane-anchored glycoprotein from epimastigote forms of Trypanosoma cruzi Y-strain
44. The serine-rich Entamoeba histolytica protein is a phosphorylated membrane protein containing O-linked terminal N-acetylglucosamine residues
45. Structure of O-linked GlcNAc transferase: Mediator of glycan-dependent signaling
46. Protein import through the nuclear pore complex is a multistep process
47. Characterization of nuclear pore protein p62 produced using baculovirus
48. Sequential O-glycosylation of nuclear pore complex protein gp62 in vitro
49. Partial cDNA sequence encoding a nuclear pore protein modified by O-linked N-acetylglucosamine
50. Nuclear pore complex contains a family of glycoproteins that includes p62: Glycosylation through a previously unidentified cellular pathway
51. An evaluation of sialation of the nucleoporin p62
52. The nuclear pore: At the crossroads
53. Nuclear pore complex: Structure, function, and regulation
54. Phosphorylation and glycosylation of nucleoporins
55. Primary sequence and heterologous expression of nuclear pore glycoprotein p62
56. Structure and function of the nuclear pore complex: New perspectives
57. Mex67p of Schizosaccharomyces pombe interacts with Raelp in mediating mRNA export
58. Patch clamp and atomic force microscopy demonstrate TATA-binding protein (TBP) interactions with the nuclear pore complex
59. Patch clamp detection of transcription factor translocation along the nuclear pore complex channel
60. The ion channel behavior of the nuclear pore complex
61. Reconstitution of HIV-1 rev nuclear export: Independent requirements for nuclear import and export
62. N-acetylglucosamine-dependent nuclear import of neoglycoproreins
63. Cell cycle-dependent phosphorylation of nucleoporins and nuclear pore membrane protein Gp210
64. Modulation of O-linked N-acetylglucosamine levels on nuclear and cytoplasmic proteins in vivo using the peptide O-GlcNAc-beta-N-acetylglucosaminidase inhibitor O-(2-acetamido-2-de-oxy-D-glucopyranosylidene)amino-N-phenylcarbamate
65. O-linked N-acetylglucosamine: The 'yin-yang' of Ser/Thr phosphorylation? Nuclear and cytoplasmic glycosylation
66. Analysis of nuclear pore protein p62 glycosylation
67. Alternative O-glycosylation/O-phosphorylation of the murine estrogen receptor beta
68. Glycosylation of chromosomal proteins: Localization of O-linked N-acetylglucosamine in Drosophila chromatin
69. Serum response element associated transcription factors in mouse embryos: Serum response factor YY1, and PEA3 factor
70. Streptozotocin, an analog of N-acetylglucosamine, blocks the removal of O-GlcNAc from intracellular proteins
71. Antibodies against the SV40 large T antigen nuclear localization sequence
72. RNA polymerase II is a glycoprotein. Modification of the COOH-terminal domain by O-GlcNAc
73. Purification and characterization of an estrogen-inducible membrane glycoprotein. Evidence that it is a transferrin receptor
74. The microtubule-associated protein tau is extensively modified with O-linked N-acetylglucosamine
75. Glycosylation of mammalian neurofilaments. Localization of multiple O-linked N-acetylglucosamine moieties on neurofilament polypeptides L and M
76. High molecular weight microtubule-associated proteins contain O-linked-N-acetylglucosamine
77. Glycosylation sites flank phosphorylation sites on synapsin I: O-linked N-acetylglucosamine residues are localized within domains mediating synapsin 1 interactions
78. The cytoskeletal protein talin is O-glycosylated
79. Synapsins contain O-linked N-acetylglucosamine
80. Nuclear glycogen and glycogen synthase kinase 3
81. Characterization and dynamics of O-linked glycosylation of human cytokeratin 8 and 18
82. Cytokeratin peptide SFGSGFGGGY mimics N-acetyl-beta-D-glucosamine in reaction with antibodies and lectins, and induces in vivo anti-carbohydrate antibody response
83. Immunological mimicry between N-acetyl-beta-D-glucosamine and cytokeratin peptides. Evidence for a microbially driven anti-keratin antibody response
84. Elevated O-linked N-acetylglucosamine metabolism in pancreatic beta-cells
85. The structure of the tetratricopeptide repeats of protein phosphatase 5: Implications for TPR-mediated protein-protein interactions
86. Structure of TPR domain-peptide complexes: Critical elements in the assembly of the Hsp70-Hsp90 multichaperone machine
87. X-ray crystal structure of rabbit Na-cetylglucosaminyltransferase I: Catalytic mechanism and a new protein superfamily
88. Streptozotocin-induced beta-cell death is independent of its inhibition of O-GlcNAcase in pancreatic Min6 cells
89. Novel immunogenic antigen homologous to hyaluronidase in meningioma
90. Glucose and streptozotocin stimulate p135 O-glycosylation in pancreatic islets
91. Glucose stimulates protein modification by O-linked GlcNAc in pancreatic beta cells: Linkage of O-linked GlcNAc to beta cell death
92. Complete inhibition of glucose-induced desensitization of the glucose transport system by inhibitors of mRNA synthesis. Evidence for rapid turnover of glutamine: Fructose-6-phosphate amidotransferase
93. Discovery of a metabolic pathway mediating glucose-induced desensitization of the glucose transport system. Role of hexosamine biosynthesis in the induction of insulin resistance
94. Coordinated regulation of glutamine: Fructose-6-phosphate amidotransferase activity by insulin, glucose, and glutamine. Role of hexosamine biosynthesis in enzyme regulation
95. Insulin regulation of pyruvate kinase activity in isolated adipocytes. Crucial role of glucose and the hexosamine biosynthesis pathway in the expression of insulin action
96. Effects of overexpression of glutamine: Fructose-6-phosphate amidotransferase (GFAT) and glucosamine treatment on translocation of GLUT4 in rat adipose cells
97. High glucose-induced transforming growth factor beta1 production is mediated by the hexosamine pathway in porcine glomerular mesangial cells
98. Expression of glutamine: Fructose-6-phosphate amidotransferase in human tissues: Evidence for high variability and distinct regulation in diabetes
99. Overexpression of glutamine: Fructose-6-phosphate-amidotransferase induces transforming growth factor-beta1 synthesis in NIH-3T3 fibroblasts
100. Increased hexosamine availability similarly impairs the action of insulin and IGF-1 on glucose disposal
101. Role of the glucosamine pathway in fatinduced insulin resistance
102. In vivo glucosamine infusion induces insulin resistance in normoglycemic but not in hyperglycemic conscious rats
103. Transmembrane assembly of N-linked glycoproteins. Studies on the topology of saccharide synthesis
104. Increased activity of the hexosamine synthesis pathway in muscles of insulin-resistant ob/ob mice
105. Phosphorylation of human glutamine: Fructose-6-phosphate amidotransferase by cAMP-dependent protein kinase at serine 205 blocks the enzyme activity
106. Hyperglycemia-induced mitochondrial superoxide overproduction activates the hexosamine pathway and induces plasminogen activator inhibitor-1 expression by increasing Sp1 glycosylation
107. In vivo effects of glucosamine on insulin secretion and insulin sensitivity in the rat: Possible relevance to the maladaptive responses to chronic hyperglycaemia
108. Mitotic arrest with nocodazole induces selective changes in the level of O-linked N-acetylglucosamine and accumulation of incompletely processed N-glycans on proteins from HT29 cells
109. Dynamic O-GlcNAcylation of the small heat shock protein alpha B-crystallin
110. Phosphorylation generates different forms of rotavirus NSP5
111. Tyrosine phosphorylation of mammalian RNA polymerase II carboxyl-terminal domain
112. Cytoplasmic O-GlcNAc modification of the head domain and the KSP repeat motif of the neurofilament protein neurofilament-H
113. Beta-amyloid precursor protein is modified with O-linked N-acetylglucosamine
114. O-linked N-acetylglucosamine is upregulated in Alzheimer brains
115. Expression, glycosylation, and phosphorylation of human keratins 8 and 18 in insect cells
116. Clathrin assembly protein AP-3 is phosphorylated and glycosylated on the 50-kDa structural domain
117. High mobility group protein. HMG-1, contains insignificant glycosyl modification
118. Characterization of the catalytic domain of Clostridium novyi alpha-toxin
119. Clostridium novyi alpha-toxin-catalyzed incorporation of GlcNAc into Rho subfamily proteins
120. Identification of a negative regulator of gibberellin action. HvSPY, in barley
121. Plant hormones: Dissecting the gibberellin response pathway
122. Reduction of O-linked N-acetylglucosamine-modified assembly protein-3 in Alzheimer's disease
123. Identification of O-linked N-acetylglucosamine modification of ankyrin G isoforms targeted to nodes of Ranvier
124. Assignment of the dystonia-parkinsonism syndrome locus. DYT3, to a small region within a 1.8-Mb YAC contig of Xql3.1
125. Genetics of dystonia
126. AFX1 and p54nrb: Fine mapping, genomic structure, and exclusion as candidate genes of X-linked dystonia parkinsonism
127. Genetics in movement disorders
128. Glucosamine inhibits glucokinase in vitro and produces a glucose-specific impairment of in vivo insulin secretion in rats
129. SV40 large T antigen is modified with O-linked N-acetylglucosamine but not with other forms of glycoslation
130. Regulation of specific DNA binding by p53: Evidence for a role for O-glycosylation and charged residues at the carboxy-terminus